Form 4 for EW Edwards Lifesciences
Accepted 2026-06-17 20:19:12 ET · period of report 2026-06-17 · accession 0001225208-26-006103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2026-06-17 20:19 | 2026-06-17 | EW | Zovighian Bernard J | CEO, Dir | S - Sale | $87.92 | -523 | 11.5K | -4% | -$46.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-17 | S | D | 523 | $87.92 | 11,516.55 | I By Trust | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |